Cargando…
Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemia
BACKGROUND: Minimal residual disease detection in the bone marrow is usually performed in patients with acute myeloid leukemia undergoing one course of induction chemotherapy. To optimize the chemotherapy strategies, more practical and sensitive markers are needed to monitor the early treatment resp...
Autores principales: | Yu, Cong, Kong, Qing-lei, Zhang, Yun-xiang, Weng, Xiang-qin, Wu, Jing, Sheng, Yan, Jiang, Chun-lei, Zhu, Yong-mei, Cao, Qi, Xiong, Shu-min, Li, Jun-min, Xi, Xiao-dong, Chen, Sai-juan, Chen, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431040/ https://www.ncbi.nlm.nih.gov/pubmed/25957890 http://dx.doi.org/10.1186/s13045-015-0145-1 |
Ejemplares similares
-
Pediatric chronic myeloid leukemia in myeloid blast crisis
por: Dey, Biswajit, et al.
Publicado: (2023) -
Current Management of Chronic Myeloid Leukemia Myeloid Blast Phase
por: Yohanan, Binoy, et al.
Publicado: (2022) -
Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration
por: Xiang, Wei, et al.
Publicado: (2015) -
De novo acute myeloid leukemia with monocytoid blasts and erythrophagocytosis
por: Blieden, Clifford, et al.
Publicado: (2014) -
Immunophenotypic evolution of blast populations in pediatric acute myeloid leukemia
por: Pereira, Welbert Oliveira, et al.
Publicado: (2016)